InsidersTradesSigma
Total declarations
Company
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
8
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-25.1%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by West Linda, Director. Officer active across 1 company, notably Galera Therapeutics, Inc.. Cumulatively, 8 disclosures have been logged. Split: 8 buys · 0 sell. Total volume traded: €531k. History available since 28 May 2021. The latest transaction was filed on 17 December 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
20,000 shares@ US$2.74029.1% of flowCommon StockSEC:0000899243-21-049012
Ideal exit: 13 Sept 2022 (T+270)
20,000 shares@ US$2.74020.30% mcap9.1% of flowCommon StockSEC:0000899243-21-049012:0
Ideal exit: 13 Sept 2022 (T+270)
10,000 shares@ US$9.1314.2% of flowCommon StockSEC:0000899243-21-024505
Ideal exit: 12 Mar 2022 (T+270)
10,000 shares@ US$9.130.47% mcap14.2% of flowCommon StockSEC:0000899243-21-024505:0
Ideal exit: 12 Mar 2022 (T+270)
10,000 shares@ US$8.65110.44% mcap13.4% of flowCommon StockSEC:0000899243-21-022167:0
Ideal exit: 27 Feb 2022 (T+270)
10,000 shares@ US$8.651113.4% of flowCommon StockSEC:0000899243-21-022167
Ideal exit: 27 Feb 2022 (T+270)
10,000 shares@ US$8.64113.4% of flowCommon StockSEC:0000899243-21-021576
Ideal exit: 22 Feb 2022 (T+270)
10,000 shares@ US$8.6410.44% mcap13.4% of flowCommon StockSEC:0000899243-21-021576:0
Ideal exit: 22 Feb 2022 (T+270)
8 of 8 declarations
About West Linda
Linda West is a Director at Galera Therapeutics, Inc. In this role, she contributes to the governance of the company and strategic decision-making. Her experience in the biopharmaceutical sector allows her to make significant contributions to board discussions.
